Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sigurdardottir, V.
Right arrow Articles by Hulthe, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sigurdardottir, V.
Right arrow Articles by Hulthe, J.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Care 27:880-884, 2004
© 2004 by the American Diabetes Association, Inc.


Epidemiology/Health Services/Psychosocial Research
Original Article

Preclinical Atherosclerosis and Inflammation in 61-Year-Old Men With Newly Diagnosed Diabetes and Established Diabetes

Vilborg Sigurdardottir, MD, Björn Fagerberg, MD, PHD and Johannes Hulthe, MD, PHD

From the Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska University Hospital, Göteborg University, Gothenburg, Sweden

Address correspondence and reprint requests to Vilborg Sigurdardottir, Wallenberg Laboratory, Physiology Group, Sahlgrenska University Hospital, S-413 45 Gothenburg, Sweden. E-mail: vilborg{at}wlab.wall.gu.se

OBJECTIVE—The aim of this study was to investigate the occurrence of subclinical atherosclerosis and underlying mechanisms in men with newly diagnosed diabetes and established diabetes compared with healthy control subjects.

RESEARCH DESIGN AND METHODS—In a population-based study of 61-year-old Caucasian men (n = 271) with established diabetes (n = 50) and newly diagnosed diabetes (n = 24) and healthy control subjects (n = 197), standard risk factors and highly sensitive (hs) C-reactive protein (CRP) were measured. Ultrasound measurements of intima-media thickness (IMT) were performed bilaterally in the common carotid artery, and a composite measure was calculated from common carotid and carotid bulb IMT (composite IMT). The plaque status was assessed.

RESULTS—Composite IMT and carotid plaque size increased gradually among the healthy control subjects, newly diagnosed diabetic patients, and established diabetic patients (P for trend <=0.001, respectively). CRP was higher in newly and established diabetes (NS between diabetes groups) compared with healthy control subjects (P < 0.001). Total cholesterol levels were lower in newly diagnosed diabetes (5.51 ± 1.13 mmol/l, P < 0.05) and established diabetes (5.45 ± 1.15 mmol/l, P < 0.01) compared with those of healthy control subjects (5.77 ± 1.03 mmol/l). In men with diabetes (n = 74), diabetes onset status (newly diagnosed versus established), waist-to-hip ratio (WHR), and serum triglycerides, but not CRP, explained 16% of the variance in composite IMT.

CONCLUSIONS—This is the first study to show increased preclinical atherosclerotic changes (IMT and plaque size) and increased inflammation (hs-CRP) in men with newly diagnosed diabetes as well as in patients with established diabetes compared with healthy control subjects. WHR, diabetes onset status (newly diagnosed versus established), and triglycerides, but not CRP, were independent correlates of carotid artery IMT in men with diabetes.

Abbreviations: CCA, common carotid artery • CRP, C-reative protein • FPG, fasting plasma glucose • hs, highly sensitive • IMT, intima-media thickness • OGTT, oral glucose tolerance test • WHR, waist-to-hip ratio


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Mita, H. Watada, T. Shimizu, Y. Tamura, F. Sato, T. Watanabe, J. B. Choi, T. Hirose, Y. Tanaka, and R. Kawamori
Nateglinide Reduces Carotid Intima-Media Thickening in Type 2 Diabetic Patients Under Good Glycemic Control
Arterioscler. Thromb. Vasc. Biol., November 1, 2007; 27(11): 2456 - 2462.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
G. Ostling, B. Hedblad, G. Berglund, and I. Goncalves
Increased Echolucency of Carotid Plaques in Patients With Type 2 Diabetes
Stroke, July 1, 2007; 38(7): 2074 - 2078.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
R. P F Dullaart, R. de Vries, A. van Tol, and W. J Sluiter
Lower plasma adiponectin is a marker of increased intima-media thickness associated with type 2 diabetes mellitus and with male gender
Eur. J. Endocrinol., March 1, 2007; 156(3): 387 - 394.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. Guan, C. Hudson, T. Wong, M. Kisilevsky, R. K. Nrusimhadevara, W. C. Lam, M. Mandelcorn, R. G. Devenyi, and J. G. Flanagan
Retinal Hemodynamics in Early Diabetic Macular Edema
Diabetes, March 1, 2006; 55(3): 813 - 818.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
P. Davidsson, J. Hulthe, B. Fagerberg, B.-M. Olsson, C. Hallberg, B. Dahllof, and G. Camejo
A proteomic study of the apolipoproteins in LDL subclasses in patients with the metabolic syndrome and type 2 diabetes
J. Lipid Res., September 1, 2005; 46(9): 1999 - 2006.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
A. Veiraiah
Hyperglycemia, Lipoprotein Glycation, and Vascular Disease
Angiology, July 1, 2005; 56(4): 431 - 438.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2004 by the American Diabetes Association.